ACTOPLUS MET XR (metformin hydrochloride; pioglitazone hydrochloride) Takeda pharms usa Patent: 8,470,368 Expiration: Sep 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical…
The post Drug Patent Expiration…
Drug Patent Expirations for the Week of September 17, 2023 Read Post »
Annual Drug Patent Expirations for ACTOPLUS+MET+XR Actoplus Met Xr is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are five patents protecting this drug…
The post New patent expiration for Takeda Pharms drug ACTOPLUS MET XR ap…
New patent expiration for Takeda Pharms drug ACTOPLUS MET XR Read Post »
TYZEKA (telbivudine) Novartis Patent: 7,589,079 Expiration: Sep 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of September 10, 2023 Read Post »
Annual Drug Patent Expirations for PROAIR+HFA Proair Hfa is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from five suppliers. There are…
The post New patent expiration for Teva Branded drug PROAIR HFA appeared first…
New patent expiration for Teva Branded drug PROAIR HFA Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Cumberland Pharms drug VIBATIV appeared …
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are two patents protecting this drug. This drug has eleven…
The post New patent expiration for Novartis drug TYZEKA appeared first on Dru…
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post New patent expiration for Merck Sharp drug TEMODAR appeared first on Dr…
New patent expiration for Merck Sharp drug TEMODAR Read Post »
Annual Drug Patent Expirations for TRI-LUMA Tri-luma is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Galderma Labs drug TRI-LUMA appeared first on D…
New patent expiration for Galderma Labs drug TRI-LUMA Read Post »
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Evofem Inc drug PHEXXI appeared first on DrugPat…
New patent expiration for Evofem Inc drug PHEXXI Read Post »
Annual Drug Patent Expirations for QUTENZA Qutenza is a drug marketed by Averitas and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent expiration for Averitas drug QUTENZA appeared first…